African genomics research is gaining momentum as countries launch national genome projects to bridge the gap in genetic data and healthcare. Currently, only about 0.15% of participants in genome-wide association studies are from Africa, despite the continent having the greatest human genetic diversity in the world. This lack of representation can lead to misinterpretation of genetic findings for African patients. Researchers stress that better information from African populations can improve diagnoses for inherited conditions and understanding of how people respond differently to medicines.
A recent study examined national genome projects across Africa and their potential to address the gap in genetic data. The study, led by a molecular geneticist at Muhimbili University of Health and Allied Sciences in Tanzania, found that national projects differ in scale and focus, and no single approach will suit every country. The researchers argue that sequencing must be accompanied by local expertise, responsible data governance, and sustained investment to improve healthcare. The study highlights the importance of involving communities in project design and setting rules for consent and data access.
Several African countries have launched national genome projects, including Tunisia, Egypt, and Senegal. Tunisia's project aims to study both people without known disease and patients with clinical conditions, while Egypt plans to study a large number of people and investigate common and rare diseases. Senegal's project seeks to include people from 31 ethnolinguistic groups across all 14 regions, addressing the risk of overlooking parts of the population. Other countries, such as Tanzania, Kenya, and South Africa, have projects at earlier stages of development.
The national genome projects offer different lessons, but all share the goal of building a better picture of genetic differences within a population and how they relate to health and disease. The projects require laboratories, computing systems, trained scientists, and health professionals who can interpret genomic information. They also need clear rules on consent, privacy, storage, and who can use genetic data. Governments and project leaders must agree on health questions, involve communities, and set rules for consent and data access before collecting samples.
The benefits of national genome projects are not automatic and depend on a country's ability to analyze data, interpret findings, and translate discoveries into healthcare. The aim is not to offer every person a genetic test but to build knowledge and develop the people and systems needed to use it. For families affected by inherited diseases, better local information may make it easier to determine whether a genetic change is linked to disease. Research may also help doctors understand why some medicines work differently between people.
African countries face challenges in implementing national genome projects, including limited resources and infrastructure. However, regional cooperation and long-term funding can help. Countries do not need large genome projects; they can start small, focus on local health problems, and expand as capacity grows. International collaboration will remain important, but countries should have meaningful control over genomic data generated from their populations.
Success in national genome projects should not be measured solely by the number of people whose complete DNA is read. Instead, the focus should be on whether the project improves the interpretation of genetic tests, helps families affected by inherited disease, and generates evidence to improve healthcare. With careful planning, responsible data governance, and sustained investment, African countries can harness the potential of genomics to improve healthcare and health outcomes for their populations.
Key points
- National genome projects are being launched across Africa to connect genetic data and healthcare.
- The projects require local expertise, responsible data governance, and sustained investment to improve healthcare.
- Success will depend on the ability to analyze data, interpret findings, and translate discoveries into healthcare.
